Medicina
Departamento
University of Tsukuba
Tsukuba, JapónPublicaciones en colaboración con investigadores/as de University of Tsukuba (10)
2022
-
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Nature communications, Vol. 13, Núm. 1, pp. 1878
2020
-
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Annals of Oncology, Vol. 31, Núm. 1, pp. 88-95
-
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
The Lancet Oncology, Vol. 21, Núm. 1, pp. 105-120
2019
-
Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?
Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 13, Núm. 4, pp. 2723-2725
-
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential
Cardiovascular Diabetology, Vol. 18, Núm. 1
2017
-
Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y
World Journal of Emergency Surgery
-
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
The Lancet, Vol. 390, Núm. 10109, pp. 2266-2277
2016
-
Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
World Journal of Emergency Surgery, Vol. 11, Núm. 1